Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Completed 15Unknown 3Terminated 3Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 487Gastrointestinal 72Breast 64Genitourinary 50Head & Neck 33Gynecologic 28Dermatologic 27CNS 27Sarcoma 19Other solid neoplasm 11Lymphoid 7Endocrine 5Plasma cell 4Other hematologic neoplasm 4Classical hematology 3Myeloid 2Other neoplasm 1Other 1NET 1

Conditions

Anemia 43Anemia, Refractory, with Excess of Blasts 40Leukemia, Myeloid, Acute 38Myelodysplastic Syndromes 36Leukemia 34Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Multiple Myeloma 25Thrombocytopenia 23Leukemia, Lymphocytic, Chronic, B-Cell 21Primary Myelofibrosis 20Lymphoma 20Lymphoma, Non-Hodgkin 19Leukemia, Myelomonocytic, Chronic 18Venous Thromboembolism 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Hodgkin Disease 16Myeloproliferative Disorders 15Lymphoma, Mantle-Cell 14Anemia, Aplastic 14Anemia, Refractory 13Lymphoma, Follicular 12Hematologic Neoplasms 12Lymphoma, Large B-Cell, Diffuse 11Congenital Abnormalities 10Neoplasms, Plasma Cell 9Myelodysplastic-Myeloproliferative Diseases 9Lymphoma, Large-Cell, Immunoblastic 9Leukemia, Myeloid, Chronic-Phase 9Burkitt Lymphoma 9

Interventions

Tinzaparin 1Epoetin Alfa 1Darbepoetin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Lung Neoplasms × Classical hematology × Clear all
NCT00310232 2024-04-02

Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)

Ontario Clinical Oncology Group (OCOG)

Phase 3 Terminated
70 enrolled
Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00858364 2022-11-30

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Amgen

Phase 3 Terminated
2,549 enrolled 19 charts
Classical hematologyThoracic

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

NCT03090880 2022-11-17

PROVE

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
59 enrolled
Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡